Delivery Order SPE2DR25D2104-SPE2DR26F3NCQ
- Not listed
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Everolimus 0.75 mg tablets (60-count units) with a contract value of $7,139.43. This firm fixed-price delivery order, issued on May 27, 2025, with an ultimate completion date of May 28, 2025, will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a non-competed delivery order under AmerisourceBergen's existing contract vehicle with the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Everolimus 5 mg tablets (30-count packages) with a ceiling value of $44,765.09. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of August 13, 2025. The award is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Everolimus 1 mg tablets (60-count) with a ceiling value of $16,540.67. This firm fixed-price delivery order is not set-aside and represents a competitive award to the prime contractor. The contract is set to be completed by July 29, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The U.S. Defense Department's Medical Supply Chain awarded a $18,147.63 delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Everolimus 10 mg tablets in quantities of 30. The contract was competitively awarded without set-aside restrictions under a firm fixed-price delivery order mechanism, with an ultimate completion date of August 28, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a prime pharmaceutical distributor for federal...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Everolimus 0.25 mg tablets (60-count unit) with a ceiling value of $10,068.17. This firm fixed-price delivery order, which is not set-aside and was competitively awarded, is scheduled for completion by August 28, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal...
- The Defense Logistics Agency awarded a $3,978.63 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Everolimus 1 mg tablets in unit dose packaging (60 count). This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of July 31, 2025. The pharmaceutical product will be delivered to the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Everolimus 10 mg tablets in unit dose packaging (28 count). This is a firm fixed-price delivery order with a ceiling value of $1,358.26 and an ultimate completion date of September 25, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a $26,956.89 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Everolimus 0.5 mg, with an ultimate completion date of September 19, 2025. This contract utilizes firm fixed pricing with no set-aside designation, indicating the award was made through open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical...
- AmerisourceBergen Drug Corp was awarded a delivery order on July 14, 2025, by the Defense Logistics Agency's Medical Supply Chain for the supply of Everolimus 10 mg tablets (unit dose, 28-count packages) with a ceiling value of $1,358.26. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of July 15, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Everolimus 0.25 mg tablets (60-count units) with a contract ceiling value of $1,800.00. This firm fixed-price delivery order represents a non-competitive award and is scheduled for completion by June 2, 2025. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3NCQDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Everolimus 0.75 mg tablets (60-count units) with a ceiling value of $14,116.76. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract is scheduled for ultimate completion on November 4, 2025, with performance of work taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which has a potential value of $999,999,999 and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency. The company's extensive federal contract portfolio demonstrates consistent capability to supply a comprehensive range of pharmaceutical products, including specialty medications, generic drugs, vaccines, and medical supplies across multiple therapeutic domains. All reviewed contract awards have been competitively procured with firm fixed pricing, showcasing the company's ability to meet federal procurement standards and deliver varied product quantities ranging from small to substantial orders. The Everolimus delivery order reflects AmerisourceBergen's ongoing role in supporting Department of Defense healthcare requirements through the DLA Troop Support Medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.1k | 11/3/25 |